Endoscopic Retrograde Cholangiopancreatography Market Size, Share, and Industry Analysis By Product (Endoscopes, Assistive Devices, (Sphincterotomes, Guidewires, Forceps, Cannulas, Balloon, Papillotomies, and Others) Visualization Systems, and Others), By Procedure (Biliary Dilation, Biliary Sphincterotomy, Biliary Stenting, Pancreatic Sphincterotomy, Pancreatic Duct Stenting, and Pancreatic Duct Dilation), By End-Use (Hospitals and ASCs, Specialty Clinics, and Others), and Regional Forecast, 2026-2034

The global endoscopic retrograde cholangiopancreatography market size was valued at USD 2.38 billion in 2025. The market is projected to grow from USD 2.58 billion in 2026 to USD 4.9 billion by 2034, exhibiting a CAGR of 8.36% during the forecast period.

The global endoscopic retrograde cholangiopancreatography (ERCP) market supports pancreatic and biliary diagnostic and therapeutic medical procedures through its established practices. Using endoscopy and fluoroscopy together as a procedure helps identify conditions including gallstones and strictures and tumors.

The market expansion results from higher gastrointestinal disorder rates together with improved technology and patient preference for nonsurgical interventions. Further growth of healthcare facilities throughout emerging markets drives the market expansion.

• According to the NIH, affected patients receive endoscopic retrograde cholangiopancreatography treatment approximately 500,000 times per year in the U.S., demonstrating its extensive application in biliary and pancreatic condition management and diagnosis.

Endoscopic RetrogradeCholangiopancreatography Market Driver

Increasing Prevalence of Pancreatic and Biliary Diseases

The global endoscopic retrograde cholangiopancreatography market experiences growth due to pancreatic and biliary illness cases increase at a rising rate including situations such as gallstones along with chronic pancreatitis and bile duct cancer diagnostic categories. As populations age and medical knowledge about early diagnosis increases together with unhealthy lifestyle patterns the market sees rising procedure need. The growth in the endoscopic retrograde cholangiopancreatography market is enhanced by technological developments which led to improvements in guidewires alongside stents and endoscopes. Healthcare infrastructure development in developing areas creates more opportunities for patients to access endoscopic retrograde cholangiopancreatography procedures.

• According to the NIH, most emergency Department procedures in North America utilize endoscopic retrograde cholangiopancreatography to manage bile duct medical problems such as gallstones together with bile duct strictures and cholangitis.

Endoscopic RetrogradeCholangiopancreatography Market Restraint

High Costs Associated with Endoscopic Retrograde Cholangiopancreatography Devices May Create Challenges for Industry Growth

The endoscopic retrograde cholangiopancreatography market worldwide encounters obstacles due to endoscopic retrograde cholangiopancreatography devices and related equipment and medical procedures prove too expensive. Treatment costs rise substantially due to of advanced endoscopes together with specialized guidewires and stents. Financial barriers appear due to skilled nursing professionals along with quality medical facilities exist as requirements. The cost barriers along with other limitations restrict the adoption of endoscopic retrograde cholangiopancreatography procedures mainly in regions requiring affordability. 

Endoscopic RetrogradeCholangiopancreatography Market Opportunity

Development of Disposable Devices to Reduce Infection Risks to Offer New Growth Opportunities

The endoscopic retrograde cholangiopancreatography market has growth potential through innovations which include designing single-use tools aimed at minimizing transmission of infections. The use of disposable duodenoscopes together with guidewires and catheters decreases infection risks while advancing patient protection. The new innovations resolve the infection control issues from reusable medical equipment while improving operative results. A rising awareness about infection prevention methods spurs the market need for disposable solutions.

Segmentation

Key Insights

The report covers the following key insights:

• Increasing prevalence of pancreatic and biliary diseases, technological advancements in endoscopic retrograde cholangiopancreatography devices, and rising demand for minimally invasive procedures, By Major Countries
• Key Technological Developments
• Overview: Development of disposable endoscopic retrograde cholangiopancreatography devices to reduce infection risks and improve patient safety, affecting overall market dynamics
• Impact of COVID-19 on the Market

Analysis By Product

Based on product analysis, the endoscopic retrograde market is subdivided into endoscopes, assistive devices (Sphincterotomes, guidewires, forceps, cannulas, balloon, papillotomies, others), visualization systems, and others.

Endoscopic retrograde cholangiopancreatography procedures require endoscopes which consist of flexible tubes containing cameras together with lighting mechanisms to enable examination and access of the bile ducts and pancreatic ducts. The advanced endoscopy technology provides better imaging quality together with more flexible instrument control which leads to enhanced diagnostic treatments. The segment is likely to grow significantly.

The assistive device group consists of guidewires along with catheters as well as sphincterotomes as well as stents and balloon dilators which support clinical procedures to take away stones and Strauch ash narrowed openings and put in stents. Medical devices available in the market serve critical purposes that boost treatment success and aid in precise procedural execution.

Analysis By Procedure

Based on procedure analysis, the endoscopic retrograde market is subdivided into biliary dilation, biliary sphincterotomy, biliary stenting, pancreatic sphincterotomy, pancreatic duct stenting, pancreatic duct dilation.

The physician uses balloon dilators during this treatment to Strauch ash narrowed bile ducts resulting from strictures or stones or tumors. The medical procedure enhances bile flow by dilating bile ducts and practitioners perform it on patients who experience duct obstructions. The procedure of biliary dilation serves a key role in diminishing the onset of jaundice together with its related medical issues. The segment may expand considerably.

The medical practitioner uses Biliary Sphincterotomy to open the sphincter of Oddi either for removing stones or for better bile drainage. Medical personnel normally conduct biliary sphincterotomy as an additional operation following stone extractions. The medical procedure holds critical importance due to it treats conditions incorporating bile duct obstruction alongside specific pancreatic disorders.

Analysis By End-Use

Based on end-use industry analysis, the endoscopic retrograde market is subdivided into hospitals and ASCs, specialty clinics, and others.

Hospitals together with Ambulatory Surgery Centers (ASCs) serve as principal endoscopic retrograde cholangiopancreatography procedure providers as they maintain specialized equipment as well as skilled personnel and expertise in handling complex medical cases while providing these services. Clinics serving critical patients perform endoscopic retrograde cholangiopancreatography procedures at hospitals while ASCs specialize in treating patients as outpatients with quicker recovery periods. User adoption of minimal invasive procedures increases the demand for endoscopic retrograde cholangiopancreatography use. The segment is likely to expand significantly.

Specialty Clinics provide gastroenterology and hepatology-specific endoscopic retrograde cholangiopancreatography services to treat bile duct and pancreatic disorders of their patients. The facilities direct customized medical treatment to patients while holding trained staff members available for endoscopic procedures. Specialty clinics have become more popular due to patients experience shorter wait periods along with individualized treatment options.

Regional Analysis

Based on region, the market has been studied across North America, Europe, Asia Pacific, South America, Middle East, and Africa.

To gain extensive insights into the market, Download for Customization

The endoscopic retrograde cholangiopancreatography market finds its primary location in North America as the area maintains superior medical infrastructure and extensive use of minimally invasive procedures performed annually in high numbers. The U.S. tops the regional segment due to there is growing recognition about pancreatic and biliary diseases combined with increased patient numbers. The market enjoys growth potential due to of leading industry players operating strongly in this region.

The European market displays significant market presence due to medical technology receives ongoing funding investments through robust healthcare infrastructure throughout the continent. Germany together with France and the U.K. play leading roles among participating countries. The adoption of endoscopic retrograde cholangiopancreatography expands due to simultaneous trends of population aging and increasing gastrointestinal disorders.

The Asia Pacific region shows quick expansion due to of improved healthcare features and growing medical tourism and better understanding of progressive diagnostic methods. Three major markets include China as well as Japan alongside India. The high prevalence of pancreatic diseases together with bile duct conditions continues to expand market demand.

The healthcare sector in South America records moderate development from improved healthcare facilities together with mounting investments in endoscopic procedures. The nations of Brazil together with Argentina stand as important markets as urban medical facilities show rising interest in using endoscopic retrograde cholangiopancreatography. Increased demand could be slowed by insufficient numbers of qualified personnel in this sector.

The Middle East and Africa markets experience growth from two factors better medical infrastructure development and a rising understanding of minimally invasive medical techniques. Three nations who substantially contribute to this market are Saudi Arabia together with the UAE and South Africa. Market expansion for endoscopic retrograde cholangiopancreatography equipment faces restrictions due to insufficient access to advanced devices in distant locations.

Key Players Covered

The report includes the profiles of the following key players:

• Boston Scientific Corporation (U.S.)
• STERIS (U.S.)
• Olympus Corporation (Japan)
• CONMED Corporation (U.S.)
• FUJIFILM Corporation (Japan)
• Medtronic (Ireland)
• Cook (U.S.)
• Medi-Globe GmbH (Germany)
• TeleMed Systems, Inc. (U.S.)

Key Industry Developments

• October 2023- To support children dealing with biliary atresia the Biliary Atresia Awareness Committee started a South African awareness initiative.
• January 2023- Advantech launched the MIO-5377R single-board computer to upgrade endoscope functionality together with enhanced reliability.